Innospec Inc. — 2014 Form 10-K
Business context and reporting period. This annual filing covers the fiscal year ended December 31, 2014; fourth-quarter figures are also summarized below. Innospec develops and sells fuel additives, oilfield chemicals, personal care and fragrance ingredients, and other specialty chemicals. Its reporting segments are Fuel Specialties, Performance Chemicals, and Octane Additives. The company’s growth strategy centers on the first two segments; Octane Additives is a declining-demand business tied largely to the transition away from leaded gasoline.
Financial performance and position
| Metric | FY 2014 | FY 2013 |
|---|---|---|
| Net sales | $960.9 million | $818.8 million |
| Gross profit / gross margin | $302.0 million / 31.4% | $255.2 million / 31.2% |
| Operating income / operating margin | $112.5 million / 11.7% | $90.6 million / 11.1% |
| Net income | $84.1 million | $77.8 million |
| Diluted EPS | $3.38 | $3.22 |
| Cash from operating activities | $106.3 million | $61.3 million |
| Cash, cash equivalents and short-term investments at year-end | $46.3 million | $86.8 million |
| Debt, including current portion | $139.4 million | $148.0 million |
| Current ratio | 1.9 | 2.6 |
FY 2014 investing cash outflow was $119.0 million, including $98.7 million for business combinations; financing cash outflow was $24.3 million. Year-end total debt including $2.2 million of finance leases was $141.6 million; net debt was $95.3 million. The revolving facility had $200 million of capacity, with $139 million drawn, and expires in December 2016. The company reported compliance with its financial covenants and expected to remain compliant for the next 12 months.
Fourth quarter: Sales were $290.7 million versus $241.6 million in Q4 2013; gross profit was $94.1 million versus $74.6 million; operating income was $44.0 million versus $26.6 million. Net income was $27.9 million versus $28.7 million, diluted EPS was $1.11 versus $1.17, and operating cash flow was $47.3 million versus $29.5 million.
Material changes versus prior year
- FY sales rose 17%. Fuel Specialties sales increased 20% to $682.2 million, supported substantially by acquisitions and growth in the Americas; Performance Chemicals sales rose 16% to $223.5 million. Octane Additives sales fell 6% to $55.2 million as demand declined and shipments to the remaining customer varied in timing.
- Operating income increased 24% to $112.5 million. Gross margin improved 0.2 percentage points to 31.4%; higher operating expenses, including acquisition-related costs and amortization, partly offset segment growth.
- Net income rose 8%, while net margin declined to 8.8% from 9.5%, reflecting a higher effective tax rate (24.2% versus 16.2%). Interest expense also increased as borrowing supported acquisitions.
- Operating cash flow improved by $45.0 million, with management citing higher earnings and significant tax-related movements. Cash and short-term investments declined by $40.5 million year over year, while debt decreased by $8.6 million.
Outlook, risks, contingencies and unusual items
- Management provided no specific numerical earnings or sales guidance. It said operations for at least the next 12 months would be funded through operating cash flow and the revolving facility, which it considered adequate for working-capital needs.
- Innospec acquired Independence Oilfield Chemicals in October 2014 for discounted consideration of $191.8 million. It recorded $35.0 million of post-acquisition sales and $0.2 million of net income. Expected deferred consideration totals $95.2 million, with $45.7 million expected approximately one year after closing and $49.5 million approximately two years after closing; part may be paid in shares at the company’s election.
- A material weakness in internal control over financial reporting involved accounting for foreign-exchange gains and losses on intercompany loans. Management said it had incorrectly recorded certain amounts in earnings rather than other comprehensive income. It reported no resulting adjustment to 2014 statements or restatement of prior years; management and the auditor nevertheless concluded that internal control over financial reporting was ineffective at year-end. Remediation was underway and not yet complete.
- Environmental remediation provisions were $34.1 million, principally for the Ellesmere Port site; management noted uncertainty about timing and scope, including the future of TEL production. Planned pension funding was $10.8 million in 2015, with estimated total contributions of $37.0 million through 2019.
- Key exposures include declining TEL demand and reliance on one remaining customer in Octane Additives; oil-price-sensitive oilfield activity; raw-material and energy costs; foreign exchange, pension assumptions, acquisition integration, customer concentration, and regulatory and environmental obligations. Shell represented 8.5% of 2014 sales. No material pending legal proceedings were reported. The filing estimates about $3 million of REACH compliance costs over the next three years.
- The auditor gave an unqualified opinion on the financial statements but an adverse opinion on internal control over financial reporting because of the material weakness. Independence’s controls were excluded from management’s year-end assessment and from the auditor’s internal-control evaluation.
Important facts for investors to verify
- Progress and independent testing of remediation for the intercompany-loan foreign-exchange control weakness, and whether any future accounting adjustments are needed.
- Independence’s operating performance, final purchase-price allocation, and the amount and form of the two contingent consideration payments.
- Liquidity and refinancing options before the $200 million revolving facility expires in December 2016, alongside the scheduled contingent payments.
- Cash generation and margin trends excluding acquisition effects, including the sustainability of 2014’s tax rate and cash-flow improvement.
- Potential changes in Ellesmere Port remediation obligations and UK pension funding requirements, as well as the pace of TEL demand decline.